Treatment Algorithms Schizophrenia New antipsychotic launches underwhelm

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

EU: Hearing Aids (Excl. Parts And Accessories) - Market Report. Analysis and Forecast to 2020

EU: Hearing Aids (Excl. Parts And Accessories) - Market Report. Analysis and Forecast to 2020

  • $ 2 161
  • Industry report
  • by IndexBox Marketing
  • December 2014

The report provides an in-depth analysis of the EU Market of Hearing Aids (Excl. Parts And Accessories). It presents the latest data of the market size and volume, domestic production, exports and imports, price dynamics and turnover in the industry. The report shows the sales data, allowing you to ...

Industries: Pathology | Countries: Europe, Czech Republic, United Kingdom, Netherlands, Luxembourg, Lithuania, World, Sweden, Spain, Slovenia, Slovakia (slovak Republic), Romania, Portugal, Poland, Malta, Latvia, Italy, Ireland, Hungary, Greece, France, Germany, Finland, Estonia, Denmark, Cyprus, Croatia, Bulgaria, Belgium, Austria

Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

Medical Affairs Reputations in Oncology (EU5): Oncologists Rate Key Products and Companies

  • $ 3 900
  • Industry report
  • by Firstword Pharma
  • December 2014

As the cancer drug market continues to face significant challenges in an environment of rising R&D costs, value-based pricing, demands for real world evidence and tougher regulation, the role of Medical Affairs teams in oncology working across the major markets of Europe - France, Germany, Italy, Spain ...

Industries: Pathology | Countries: Europe

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023

  • $ 3 995
  • Industry report
  • by Global Data
  • December 2014
  • 48 pages

EpiCast Report: Rheumatoid Arthritis - Epidemiology Forecast to 2023 Summary Rheumatoid arthritis (RA) is an autoimmune disease that causes inflammation of the joints. In RA, the body's immune system attacks the lining of the joints causing an inflammatory response. RA is characterized by joint swelling, ...

Industries: Pathology | Countries: Japan, India, China, World, Australia, Spain, Italy, France, Germany, United States, United Kingdom, Europe

Key Pharma News 01 DECEMBER 2014

Key Pharma News 01 DECEMBER 2014

  • $ 1 415
  • Industry report
  • by Espicom Business Intelligence
  • December 2014
  • 32 pages

Industry Trend Analysis - Merck KGaA/Pfizer Alliance Is Strategic Move For Both In Immuno-Oncology Industry Trend Analysis - CAR-T Therapy Arena Heats Up With Another Biotech Collaboration Industry Trend Analysis - Continued Focus On European Generics Sales Important For STADA Industry Trend Analysis ...

Industries: Pathology | Countries: Japan, Brazil, Russian Federation, Europe, World, United States

APOGEPHA Arzneimittel GmbH SWOT Analysis, Strategy, Revenues and Profits

APOGEPHA Arzneimittel GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: Slovenia, Portugal, Italy, Ireland, Greece, Germany, Croatia, Belgium, Europe

Eisai GmbH SWOT Analysis, Strategy, Revenues and Profits

Eisai GmbH SWOT Analysis, Strategy, Revenues and Profits

  • $ 300
  • Company report
  • by Global Data
  • November 2014
  • 15 pages

This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in no later than 2 business days. SWOT Analysis report provides you a strategic analysis and detailed ...

Industries: Pathology | Countries: Europe, Germany, Switzerland, Netherlands, United States, Sweden, Spain, Slovakia (slovak Republic), Russian Federation, Portugal, Norway, Italy, Ireland, France, Finland, Denmark, Austria, Japan, World

 Angina (Angina Pectoris)-API Insights, 2014

Angina (Angina Pectoris)-API Insights, 2014

  • $ 1 250
  • Industry report
  • by Delve Insight
  • November 2014

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the ...

Industries: Pathology | Countries: United States, World, India, China, Asia, North America, Singapore, Europe, Japan

 Athlete%s Foot (Tinea Pedis)-API Insights, 2014

Athlete%s Foot (Tinea Pedis)-API Insights, 2014

  • $ 1 250
  • Industry report
  • by Delve Insight
  • November 2014

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the ...

Industries: Pathology | Countries: United States, World, India, China, Asia, North America, Singapore, Europe, Japan

 Epilepsy-API Insights, 2014

Epilepsy-API Insights, 2014

  • $ 1 250
  • Industry report
  • by Delve Insight
  • November 2014

Summary The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the ...

Industries: Pathology | Countries: United States, World, India, China, Asia, North America, Singapore, Europe, Japan

Brinzolamide  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Brinzolamide - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Company report
  • by Ark Patent Intelligence
  • October 2014

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Pathology | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.